dejected
发表于 2025-3-21 18:03:13
书目名称Monolithic Diode-Laser Arrays影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0639027<br><br> <br><br>书目名称Monolithic Diode-Laser Arrays影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0639027<br><br> <br><br>书目名称Monolithic Diode-Laser Arrays网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0639027<br><br> <br><br>书目名称Monolithic Diode-Laser Arrays网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0639027<br><br> <br><br>书目名称Monolithic Diode-Laser Arrays被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0639027<br><br> <br><br>书目名称Monolithic Diode-Laser Arrays被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0639027<br><br> <br><br>书目名称Monolithic Diode-Laser Arrays年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0639027<br><br> <br><br>书目名称Monolithic Diode-Laser Arrays年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0639027<br><br> <br><br>书目名称Monolithic Diode-Laser Arrays读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0639027<br><br> <br><br>书目名称Monolithic Diode-Laser Arrays读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0639027<br><br> <br><br>
EXUDE
发表于 2025-3-21 21:43:02
http://reply.papertrans.cn/64/6391/639027/639027_2.png
convulsion
发表于 2025-3-22 01:10:09
http://reply.papertrans.cn/64/6391/639027/639027_3.png
诱使
发表于 2025-3-22 05:13:45
Textbook 1994 arrays and optical amplifiers. However, only a few design approaches have emerged with the potential for producing high-power, high-brightness monolithic sources. Although semiconductor-diode lasers are the most compact, highest gain and most efficient laser sources, challenges remain in developing
止痛药
发表于 2025-3-22 11:45:40
http://reply.papertrans.cn/64/6391/639027/639027_5.png
intoxicate
发表于 2025-3-22 16:51:45
http://reply.papertrans.cn/64/6391/639027/639027_6.png
强行引入
发表于 2025-3-22 19:08:27
978-3-642-78944-1Springer-Verlag Berlin Heidelberg 1994
Maximize
发表于 2025-3-22 21:20:15
http://reply.papertrans.cn/64/6391/639027/639027_8.png
Contort
发表于 2025-3-23 04:06:26
Pharmacologic Interventions in Patients with Peripheral Arterial Disease,atherosclerotic vascular disease and type 2 diabetes including the PAD patients. All patients with PAD should be considered for aggressive pharmacological management that is likely to positively impact their overall major adverse cardiovascular and limb events.
临时抱佛脚
发表于 2025-3-23 06:25:25
http://reply.papertrans.cn/64/6391/639027/639027_10.png